Safilo Group S.p.A. (SAFLF)
OTCMKTS
· Delayed Price · Currency is USD
0.7600
0.00 (0.00%)
May 14, 2025, 4:00 PM EDT
Safilo Group Revenue
In the year 2024, Safilo Group had annual revenue of 993.22M EUR, down -3.08%. Safilo Group had revenue of 461.26M in the half year ending December 31, 2024, a decrease of -8.82%.
Revenue
993.22M EUR
Revenue Growth
-3.08%
P/S Ratio
0.40
Revenue / Employee
272.49K EUR
Employees
3,645
Market Cap
413.45M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 993.22M | -31.51M | -3.08% |
| Dec 31, 2023 | 1.02B | -52.01M | -4.83% |
| Dec 31, 2022 | 1.08B | 107.16M | 11.05% |
| Dec 31, 2021 | 969.58M | 189.29M | 24.26% |
| Dec 31, 2020 | 780.30M | -158.74M | -16.90% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 200.90M |
| Elite Pharmaceuticals | 70.00M |
| Northwest Biotherapeutics | 1.38M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |
Safilo Group News
- 2 months ago - Safilo Group SpA (STU:S5U5) Q4 2024 Earnings Call Highlights: Resilience Amidst Challenges - GuruFocus